Related Experiment Videos
Cytogenetic analysis in transitional cell carcinoma of the bladder
R F Schapers1, A W Smeets, R P Pauwels
1Department of Pathology, St Maartens Gasthuis, Venlo, The Netherlands.
British Journal of Urology
|December 1, 1993
Summary
Numerical chromosomal abnormalities in transitional cell carcinoma (TCC) predict patient outcomes. Diploid tumors show better survival and progression-free survival than hyperdiploid ones, especially in superficial bladder cancers.
Area of Science:
- Urology
- Oncology
- Cytogenetics
Background:
- Transitional cell carcinoma (TCC) is the most common type of bladder cancer.
- Predicting the clinical behavior of TCC is crucial for effective patient management.
- Numerical chromosomal abnormalities may serve as prognostic markers.
Purpose of the Study:
- To investigate the predictive value of numerical chromosomal abnormalities in TCC.
- To assess the impact of chromosomal abnormalities on patient survival and progression-free survival.
Main Methods:
- Analysis of 91 patients with TCC treated by transurethral resection.
- Evaluation of chromosomal modal number (diploid vs. hyperdiploid) and cell populations.
- Multivariate analysis incorporating tumor grade, stage, mitotic index, age, and sex.
Main Results:
- Patients with diploid TCC tumors had significantly better survival and progression-free survival than those with hyperdiploid tumors.
- Tumor category was the most significant factor for overall survival in multivariate analysis.
- For superficial tumors (Ta, T1), modal chromosome number was the key predictor of survival and progression-free survival.
Conclusions:
- Modal chromosome number is a valuable predictor of survival in superficial TCC.
- Modal chromosome number is a significant predictor of progression-free survival across all TCC categories.
- Cytogenetic analysis can aid in risk stratification and treatment planning for TCC patients.